首页 > 最新文献

Infectious Disease Reports最新文献

英文 中文
Infection Rate and Risk Factors of SARS-CoV-2 Infection in Retail Workers at the Onset of the COVID-19 Pandemic, Quebec, Canada. 加拿大魁北克省2019冠状病毒病大流行初期零售从业人员SARS-CoV-2感染率及危险因素分析
IF 3.4 Q2 INFECTIOUS DISEASES Pub Date : 2024-12-16 DOI: 10.3390/idr16060098
Kim Santerre, Mathieu Thériault, Nicholas Brousseau, Marc-André Langlois, Corey Arnold, Joelle N Pelletier, Caroline Gilbert, Jean-François Masson, Mariana Baz, Denis Boudreau, Sylvie Trottier

Background/Objectives: During the pandemic, client-facing workers were perceived to be at greater risk of SARS-CoV-2 infection. This study investigated the risk factors for SARS-CoV-2 infection among a cohort of 304 retail workers in the Quebec City metropolitan area. Methods: After providing consent, participants were interviewed to gather information on demographic, socioeconomic, behavioural, and occupational variables. They were subsequently followed for up to five visits, scheduled every 12 ± 4 weeks. The study covered critical periods before and during the emergence of the Omicron variants and included retrospective reporting of COVID-19 symptoms and virus detection tests to capture the pandemic's early stages. Results: During the observation period, 173 (57%) participants experienced a first episode of COVID-19. Serological evidence of recent infection was detected in 160 participants (53%), while 117 (38%) reported a positive virus detection test. In adjusted analyses, risk factors for infection included younger age, a diagnosis of lung disease, longer weekly working hours, more frequent social gatherings, and having received fewer than three doses of vaccine. Notably, the increased risk associated with younger age and longer working hours was observed only after the relaxation of public health measures in the spring of 2022. Conclusions: These data suggest that during the early years of the pandemic when strict public health measures were in place, retail work was not a significant risk factor for SARS-CoV-2 infection in Quebec City metropolitan area. These findings highlight the complex dynamics of COVID-19 transmission and the effectiveness of workplace protective measures.

背景/目的:在大流行期间,面向客户的工作人员被认为感染SARS-CoV-2的风险更大。本研究调查了魁北克市区304名零售工人感染SARS-CoV-2的危险因素。方法:在提供同意后,对参与者进行访谈,以收集人口统计、社会经济、行为和职业变量的信息。随后随访5次,每12±4周。该研究涵盖了欧米克隆变异出现之前和期间的关键时期,包括对COVID-19症状的回顾性报告和病毒检测测试,以捕捉大流行的早期阶段。结果:在观察期间,173名(57%)参与者首次出现COVID-19发作。在160名参与者(53%)中检测到最近感染的血清学证据,而117名(38%)报告了病毒检测试验阳性。在调整后的分析中,感染的危险因素包括年龄较小、诊断为肺部疾病、每周工作时间较长、社交聚会更频繁以及接种的疫苗少于三剂。值得注意的是,只有在2022年春季放松公共卫生措施之后,才观察到与年龄较小和工作时间较长的相关的风险增加。结论:这些数据表明,在大流行的最初几年,当严格的公共卫生措施实施时,零售工作不是魁北克市大都市区SARS-CoV-2感染的重要危险因素。这些发现凸显了COVID-19传播的复杂动态以及工作场所防护措施的有效性。
{"title":"Infection Rate and Risk Factors of SARS-CoV-2 Infection in Retail Workers at the Onset of the COVID-19 Pandemic, Quebec, Canada.","authors":"Kim Santerre, Mathieu Thériault, Nicholas Brousseau, Marc-André Langlois, Corey Arnold, Joelle N Pelletier, Caroline Gilbert, Jean-François Masson, Mariana Baz, Denis Boudreau, Sylvie Trottier","doi":"10.3390/idr16060098","DOIUrl":"10.3390/idr16060098","url":null,"abstract":"<p><p><b>Background/Objectives:</b> During the pandemic, client-facing workers were perceived to be at greater risk of SARS-CoV-2 infection. This study investigated the risk factors for SARS-CoV-2 infection among a cohort of 304 retail workers in the Quebec City metropolitan area. <b>Methods:</b> After providing consent, participants were interviewed to gather information on demographic, socioeconomic, behavioural, and occupational variables. They were subsequently followed for up to five visits, scheduled every 12 ± 4 weeks. The study covered critical periods before and during the emergence of the Omicron variants and included retrospective reporting of COVID-19 symptoms and virus detection tests to capture the pandemic's early stages. <b>Results:</b> During the observation period, 173 (57%) participants experienced a first episode of COVID-19. Serological evidence of recent infection was detected in 160 participants (53%), while 117 (38%) reported a positive virus detection test. In adjusted analyses, risk factors for infection included younger age, a diagnosis of lung disease, longer weekly working hours, more frequent social gatherings, and having received fewer than three doses of vaccine. Notably, the increased risk associated with younger age and longer working hours was observed only after the relaxation of public health measures in the spring of 2022. <b>Conclusions:</b> These data suggest that during the early years of the pandemic when strict public health measures were in place, retail work was not a significant risk factor for SARS-CoV-2 infection in Quebec City metropolitan area. These findings highlight the complex dynamics of COVID-19 transmission and the effectiveness of workplace protective measures.</p>","PeriodicalId":13579,"journal":{"name":"Infectious Disease Reports","volume":"16 6","pages":"1240-1253"},"PeriodicalIF":3.4,"publicationDate":"2024-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11675805/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142894240","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiofilm Activity of Epinecidin-1 and Its Variants Against Drug-Resistant Candida krusei and Candida tropicalis Isolates from Vaginal Candidiasis Patients. Epinecidin-1及其变异体对阴道念珠菌病耐药克鲁氏念珠菌和热带念珠菌的抗菌活性研究
IF 3.4 Q2 INFECTIOUS DISEASES Pub Date : 2024-12-12 DOI: 10.3390/idr16060096
Sivakumar Jeyarajan, Sukumar Ranjith, Raja Veerapandian, Kalimuthusamy Natarajaseenivasan, Prahalathan Chidambaram, Anbarasu Kumarasamy
<p><p><b>Background/Objective:</b> Indwelling intrauterine contraceptive devices (IUDs) have surfaces that facilitate the attachment of <i>Candida</i> spp., creating a suitable environment for biofilm formation. Due to this, vulvovaginal candidiasis (VVC) is frequently linked to IUD usage, necessitating the prompt removal of these devices for effective treatment. In this study, we evaluated the susceptibility of antimicrobial peptides in vitro against biofilm forming, Amphotericin B (MIC50 > 2 mg L<sup>-1</sup>) resistant <i>Candida krusei</i> and <i>Candida tropicalis</i> isolated from IUD users who had signs of vaginal candidiasis (hemorrhage, pelvic pain, inflammation, itching, and vaginal discharge). Three antimicrobial peptides, namely, epinecidin-1 (epi-1) and its two variants, namely, variant-1 (Var-1) and variant-2 (Var-2), which were reported to have enhanced antibacterial activity were tested against IUD isolates (<i>C. krusei</i> and <i>C. tropicalis</i>) with pathogenic form of <i>Candida albicans</i> as control. Variants of epi-1, namely, Var-1 and Var-2 were created by substituting lysine in the place of histidine and alanine. <b>Methods:</b> The antimicrobial activity was measured using the microbroth dilution method to determine the minimum inhibitory concentration (MIC) of peptides against <i>C. albicans</i>, <i>C. krusei</i> and <i>C. tropicalis</i>. The MIC of each peptide was used for biofilm assay by Crystal violet staining, Scanning Electron Microscopy, and Reactive Oxygen Species (ROS) assay. To find the possible mechanism of anti-biofilm activity by the peptides, their ability to interact with <i>Candida</i> spp. cell membrane proteins such as Exo-β-(1,3)-Glucanase, Secreted Aspartic Proteinase (Sap) 1, and N-terminal Domain Adhesin: Als 9-2 were determined through PatchDock. <b>Results:</b> The MIC values of peptides: epi-1, var-1 and var-2 against <i>C. albicans</i> are 128 μg mL<sup>-1</sup>, 64 μg mL<sup>-1</sup> and 32 μg mL<sup>-1</sup>, <i>C. tropicalis</i> are 256 μg mL<sup>-1</sup>, 64 μg mL<sup>-1,</sup> and 32 μg mL<sup>-1</sup> and <i>C. krusei</i> are 128 µg mL<sup>-1</sup>, 128 µg mL<sup>-1</sup> and 64 µg mL<sup>-1</sup>, respectively. Both the variants outperformed epi-1. Specifically for tested <i>Candida</i> spp., var-1 showed two- to four-fold enhancements and var-2 showed two- to eight-fold enhancements compared to epi-1. Electron microscopy confirmed that the mechanism of action involves pore formation thus inducing reactive oxygen species in <i>Candida</i> spp. cell membrane. Computational analysis showed that the peptides have a high tendency to interact with <i>Candida</i> spp. cell membrane proteins such as Exo-β-(1,3)-Glucanase, Secreted Aspartic Proteinase (Sap) 1, and N-terminal Domain Adhesin: Als 9-2, thereby preventing biofilm formation. <b>Conclusions:</b> The in vitro evidence supports the potential use of epi-1 and its variants to be used as an anti-biofilm agent to coat IUDs in the future
背景/目的:留置宫内节育器(iud)具有有利于念珠菌附着的表面,为生物膜的形成创造了适宜的环境。因此,外阴阴道念珠菌病(VVC)经常与宫内节育器的使用有关,需要及时取出这些装置以进行有效治疗。在这项研究中,我们评估了体外抗菌肽对生物膜形成的敏感性,两性霉素B (MIC50 bbb2 mg L-1)耐药克鲁西假丝酵母和热带假丝酵母分离自有阴道念珠菌病症状(出血、盆腔疼痛、炎症、瘙痒和阴道分泌物)的宫内节育器使用者。以致病性白色念珠菌为对照,研究了三种抗菌肽epinecidin-1 (epi-1)及其变体变体变体1 (Var-1)和变体2 (Var-2)对krusei C.和热带C. IUD分离株的抑菌活性。epi-1的变体Var-1和Var-2是通过用赖氨酸取代组氨酸和丙氨酸而产生的。方法:采用微肉汤稀释法测定抗菌肽对白色念珠菌、克鲁氏念珠菌和热带念珠菌的最低抑菌浓度。每个肽段的MIC分别用于结晶紫染色、扫描电镜和活性氧(ROS)测定生物膜。通过PatchDock检测其与念珠菌细胞膜蛋白Exo-β-(1,3)-葡聚糖酶、分泌的天冬氨酸蛋白酶(Sap) 1、n端结构域粘附素al9 -2等相互作用的能力,探讨其抗生物膜活性的可能机制。结果:epi-1、var-1和var-2肽对白色念珠菌的MIC值分别为128 μg mL-1、64 μg mL-1和32 μg mL-1,热带念珠菌的MIC值分别为256 μg mL-1、64 μg mL-1, 32 μg mL-1和克鲁西念珠菌的MIC值分别为128 μg mL-1、128 μg mL-1和64 μg mL-1。这两种变体的表现都优于epi-1。具体来说,与epi-1相比,var-1表现出2至4倍的增强,var-2表现出2至8倍的增强。电镜证实其作用机制涉及到在念珠菌细胞膜上形成孔从而诱导活性氧的产生。计算分析表明,这些肽具有与念珠菌细胞膜蛋白如Exo-β-(1,3)-葡聚糖酶、分泌的天冬氨酸蛋白酶(Sap) 1和n端结构域粘附素al9 -2相互作用的高度倾向,从而阻止生物膜的形成。结论:体外证据支持epi-1及其变体在未来作为一种抗生物膜剂用于宫内节育器的治疗目的。
{"title":"Antibiofilm Activity of Epinecidin-1 and Its Variants Against Drug-Resistant <i>Candida krusei</i> and <i>Candida tropicalis</i> Isolates from Vaginal Candidiasis Patients.","authors":"Sivakumar Jeyarajan, Sukumar Ranjith, Raja Veerapandian, Kalimuthusamy Natarajaseenivasan, Prahalathan Chidambaram, Anbarasu Kumarasamy","doi":"10.3390/idr16060096","DOIUrl":"10.3390/idr16060096","url":null,"abstract":"&lt;p&gt;&lt;p&gt;&lt;b&gt;Background/Objective:&lt;/b&gt; Indwelling intrauterine contraceptive devices (IUDs) have surfaces that facilitate the attachment of &lt;i&gt;Candida&lt;/i&gt; spp., creating a suitable environment for biofilm formation. Due to this, vulvovaginal candidiasis (VVC) is frequently linked to IUD usage, necessitating the prompt removal of these devices for effective treatment. In this study, we evaluated the susceptibility of antimicrobial peptides in vitro against biofilm forming, Amphotericin B (MIC50 &gt; 2 mg L&lt;sup&gt;-1&lt;/sup&gt;) resistant &lt;i&gt;Candida krusei&lt;/i&gt; and &lt;i&gt;Candida tropicalis&lt;/i&gt; isolated from IUD users who had signs of vaginal candidiasis (hemorrhage, pelvic pain, inflammation, itching, and vaginal discharge). Three antimicrobial peptides, namely, epinecidin-1 (epi-1) and its two variants, namely, variant-1 (Var-1) and variant-2 (Var-2), which were reported to have enhanced antibacterial activity were tested against IUD isolates (&lt;i&gt;C. krusei&lt;/i&gt; and &lt;i&gt;C. tropicalis&lt;/i&gt;) with pathogenic form of &lt;i&gt;Candida albicans&lt;/i&gt; as control. Variants of epi-1, namely, Var-1 and Var-2 were created by substituting lysine in the place of histidine and alanine. &lt;b&gt;Methods:&lt;/b&gt; The antimicrobial activity was measured using the microbroth dilution method to determine the minimum inhibitory concentration (MIC) of peptides against &lt;i&gt;C. albicans&lt;/i&gt;, &lt;i&gt;C. krusei&lt;/i&gt; and &lt;i&gt;C. tropicalis&lt;/i&gt;. The MIC of each peptide was used for biofilm assay by Crystal violet staining, Scanning Electron Microscopy, and Reactive Oxygen Species (ROS) assay. To find the possible mechanism of anti-biofilm activity by the peptides, their ability to interact with &lt;i&gt;Candida&lt;/i&gt; spp. cell membrane proteins such as Exo-β-(1,3)-Glucanase, Secreted Aspartic Proteinase (Sap) 1, and N-terminal Domain Adhesin: Als 9-2 were determined through PatchDock. &lt;b&gt;Results:&lt;/b&gt; The MIC values of peptides: epi-1, var-1 and var-2 against &lt;i&gt;C. albicans&lt;/i&gt; are 128 μg mL&lt;sup&gt;-1&lt;/sup&gt;, 64 μg mL&lt;sup&gt;-1&lt;/sup&gt; and 32 μg mL&lt;sup&gt;-1&lt;/sup&gt;, &lt;i&gt;C. tropicalis&lt;/i&gt; are 256 μg mL&lt;sup&gt;-1&lt;/sup&gt;, 64 μg mL&lt;sup&gt;-1,&lt;/sup&gt; and 32 μg mL&lt;sup&gt;-1&lt;/sup&gt; and &lt;i&gt;C. krusei&lt;/i&gt; are 128 µg mL&lt;sup&gt;-1&lt;/sup&gt;, 128 µg mL&lt;sup&gt;-1&lt;/sup&gt; and 64 µg mL&lt;sup&gt;-1&lt;/sup&gt;, respectively. Both the variants outperformed epi-1. Specifically for tested &lt;i&gt;Candida&lt;/i&gt; spp., var-1 showed two- to four-fold enhancements and var-2 showed two- to eight-fold enhancements compared to epi-1. Electron microscopy confirmed that the mechanism of action involves pore formation thus inducing reactive oxygen species in &lt;i&gt;Candida&lt;/i&gt; spp. cell membrane. Computational analysis showed that the peptides have a high tendency to interact with &lt;i&gt;Candida&lt;/i&gt; spp. cell membrane proteins such as Exo-β-(1,3)-Glucanase, Secreted Aspartic Proteinase (Sap) 1, and N-terminal Domain Adhesin: Als 9-2, thereby preventing biofilm formation. &lt;b&gt;Conclusions:&lt;/b&gt; The in vitro evidence supports the potential use of epi-1 and its variants to be used as an anti-biofilm agent to coat IUDs in the future","PeriodicalId":13579,"journal":{"name":"Infectious Disease Reports","volume":"16 6","pages":"1214-1229"},"PeriodicalIF":3.4,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11675185/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142894185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug-Resistant Tuberculosis Hotspots in Oliver Reginald Tambo District Municipality, Eastern Cape, South Africa. 南非东开普省奥利弗·雷金纳德·坦博区市耐药结核病热点地区。
IF 3.4 Q2 INFECTIOUS DISEASES Pub Date : 2024-12-06 DOI: 10.3390/idr16060095
Lindiwe Modest Faye, Mojisola Clara Hosu, Teke Apalata

Background: The global push to eliminate tuberculosis (TB) as a public health threat is increasingly urgent, particularly in high-burden areas like the Oliver Reginald Tambo District Municipality, South Africa. Drug-resistant TB (DR-TB) poses a significant challenge to TB control efforts and is a leading cause of TB-related deaths. This study aimed to assess DR-TB transmission patterns and predict future cases using geospatial and predictive modeling techniques.

Methods: A retrospective cross-sectional study was conducted across five decentralized DR-TB facilities in the O.R. Tambo District Municipality from January 2018 to December 2020. Data were obtained from Statistics South Africa, and patient GPS coordinates were used to identify clusters of DR-TB cases via DBSCAN clustering. Hotspot analysis (Getis-Ord Gi) was performed, and two predictive models (Linear Regression and Random Forest) were developed to estimate future DR-TB cases. Analyses were conducted using Python 3.8 and R 4.1.1, with significance set at p < 0.05.

Results: A total of 456 patients with DR-TB were enrolled, with 56.1% males and 43.9% females. The mean age was 37.5 (±14.9) years. The incidence of DR-TB was 11.89 cases per 100,000 population, with males being disproportionately affected. Key risk factors included poverty, lack of education, and occupational exposure. The DR-TB types included RR-TB (60%), MDR-TB (30%), Pre-XDR-TB (5%), XDR-TB (3%), and INHR-TB (2%). Spatial analysis revealed significant clustering in socio-economically disadvantaged areas. A major cluster was identified, along with a distinct outlier. The analyses of DR-TB case trends using historical data (2018-2021) and projections (2022-2026) from Linear Regression and Random Forest models reveal historical data with a sharp decline in DR-TB case, from 186 in 2018 to 15 in 2021, highlighting substantial progress. The Linear Regression model predicts a continued decline to zero cases by 2026, with an R2 = 0.865, a mean squared error (MSE) of 507.175, and a mean absolute error (MAE) of 18.65. Conversely, the Random Forest model forecasts stabilization to around 30-50 cases annually after 2021, achieving an R2 = 0.882, an MSE of 443.226, and an MAE of 19.03. These models underscore the importance of adaptive strategies to sustain progress and avoid plateauing in DR-TB reduction efforts.

Conclusions: This study highlights the need for targeted interventions in vulnerable populations to curb DR-TB transmission and improve treatment outcomes.

背景:全球努力消除作为公共卫生威胁的结核病日益紧迫,特别是在高负担地区,如南非奥利弗雷金纳德坦博区市。耐药结核病(DR-TB)对结核病控制工作构成重大挑战,是结核病相关死亡的主要原因。这项研究旨在评估耐药结核病的传播模式,并利用地理空间和预测建模技术预测未来的病例。方法:从2018年1月至2020年12月,对O.R.坦博区市的五个分散的耐药结核病设施进行了回顾性横断面研究。数据来自南非统计局,并使用患者GPS坐标通过DBSCAN聚类来确定耐药结核病例聚类。采用热点分析(Getis-Ord Gi),并建立了线性回归和随机森林两种预测模型来估计未来的耐药结核病病例。使用Python 3.8和R 4.1.1进行分析,p < 0.05为显著性。结果:共纳入456例耐药结核病患者,其中男性56.1%,女性43.9%。平均年龄37.5(±14.9)岁。耐药结核病的发病率为每10万人11.89例,男性受到的影响尤为严重。主要风险因素包括贫困、缺乏教育和职业暴露。耐药结核类型包括耐药结核(60%)、耐多药结核(30%)、Pre-XDR-TB(5%)、XDR-TB(3%)和INHR-TB(2%)。空间分析显示,社会经济条件较差的地区具有显著的聚集性。确定了一个主要的星团,以及一个明显的异常值。利用历史数据(2018-2021年)和线性回归模型和随机森林模型预测(2022-2026年)对耐药结核病病例趋势进行的分析显示,历史数据显示耐药结核病病例急剧下降,从2018年的186例下降到2021年的15例,突出了重大进展。线性回归模型预测到2026年病例数将持续下降至零,R2 = 0.865,均方误差(MSE)为507.175,平均绝对误差(MAE)为18.65。相反,随机森林模型预测2021年后稳定在每年30-50例左右,实现R2 = 0.882, MSE为443.226,MAE为19.03。这些模型强调了适应性战略在减少耐药结核病工作中保持进展和避免停滞的重要性。结论:本研究强调需要对弱势人群进行有针对性的干预,以遏制耐药结核病的传播并改善治疗结果。
{"title":"Drug-Resistant Tuberculosis Hotspots in Oliver Reginald Tambo District Municipality, Eastern Cape, South Africa.","authors":"Lindiwe Modest Faye, Mojisola Clara Hosu, Teke Apalata","doi":"10.3390/idr16060095","DOIUrl":"10.3390/idr16060095","url":null,"abstract":"<p><strong>Background: </strong>The global push to eliminate tuberculosis (TB) as a public health threat is increasingly urgent, particularly in high-burden areas like the Oliver Reginald Tambo District Municipality, South Africa. Drug-resistant TB (DR-TB) poses a significant challenge to TB control efforts and is a leading cause of TB-related deaths. This study aimed to assess DR-TB transmission patterns and predict future cases using geospatial and predictive modeling techniques.</p><p><strong>Methods: </strong>A retrospective cross-sectional study was conducted across five decentralized DR-TB facilities in the O.R. Tambo District Municipality from January 2018 to December 2020. Data were obtained from Statistics South Africa, and patient GPS coordinates were used to identify clusters of DR-TB cases via DBSCAN clustering. Hotspot analysis (Getis-Ord Gi) was performed, and two predictive models (Linear Regression and Random Forest) were developed to estimate future DR-TB cases. Analyses were conducted using Python 3.8 and R 4.1.1, with significance set at <i>p</i> < 0.05.</p><p><strong>Results: </strong>A total of 456 patients with DR-TB were enrolled, with 56.1% males and 43.9% females. The mean age was 37.5 (±14.9) years. The incidence of DR-TB was 11.89 cases per 100,000 population, with males being disproportionately affected. Key risk factors included poverty, lack of education, and occupational exposure. The DR-TB types included RR-TB (60%), MDR-TB (30%), Pre-XDR-TB (5%), XDR-TB (3%), and INHR-TB (2%). Spatial analysis revealed significant clustering in socio-economically disadvantaged areas. A major cluster was identified, along with a distinct outlier. The analyses of DR-TB case trends using historical data (2018-2021) and projections (2022-2026) from Linear Regression and Random Forest models reveal historical data with a sharp decline in DR-TB case, from 186 in 2018 to 15 in 2021, highlighting substantial progress. The Linear Regression model predicts a continued decline to zero cases by 2026, with an R<sup>2</sup> = 0.865, a mean squared error (MSE) of 507.175, and a mean absolute error (MAE) of 18.65. Conversely, the Random Forest model forecasts stabilization to around 30-50 cases annually after 2021, achieving an R<sup>2</sup> = 0.882, an MSE of 443.226, and an MAE of 19.03. These models underscore the importance of adaptive strategies to sustain progress and avoid plateauing in DR-TB reduction efforts.</p><p><strong>Conclusions: </strong>This study highlights the need for targeted interventions in vulnerable populations to curb DR-TB transmission and improve treatment outcomes.</p>","PeriodicalId":13579,"journal":{"name":"Infectious Disease Reports","volume":"16 6","pages":"1197-1213"},"PeriodicalIF":3.4,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11675276/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142894191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The First-Ever Encounter with Salmonella enterica Serovar Hvittingfoss Causing Acute Gastroenteritis in India: A Case Report. 在印度首次遇到引起急性肠胃炎的肠道沙门氏菌血清型Hvittingfoss:一个病例报告。
IF 3.4 Q2 INFECTIOUS DISEASES Pub Date : 2024-12-02 DOI: 10.3390/idr16060094
Mahadevaiah Neelambike Sumana, Morubagal Raghavendra Rao, Deepashree Rajshekar, Krishna Karthik, Nikita K Shah, Veerabhadra Swamy, Chinchana Shylaja Eshwar, Yogeesh D Maheshwarappa

Background:Salmonella enterica serovar Hvittingfoss, a member of the non-typhoidal Salmonella group, is an important foodborne serovar most frequently identified in regions (Australia, Belgium, and the United States) with active surveillance systems. This serovar has been implicated in outbreaks of foodborne illness. Soft cheese, crab cocktail, beef, and rock melon are commonly involved in these outbreaks. Although the definitive host of this serovar is not yet established, Salmonella Hvittingfoss can be found in wild animals (Feral pigs), bird populations (Bar-tailed godwit, Plumed whistling ducks, White-naped crane, and Sharp-tailed sandpiper), and domestic birds like chickens. Case presentation: We report the first case of Salmonella enterica serovar Hvittingfoss causing acute gastroenteritis in a 52-year-old male labourer and agriculturist from a rural area of Mysuru, South India. This is the first documented case of Salmonella Hvittingfoss causing acute gastroenteritis in India. Conclusions: While non-typhoidal Salmonella infections typically resolve on their own, they can be particularly dangerous for certain demographics, such as children, the elderly, and those with compromised immune systems. Therefore, studying the different serotypes of these infections in both clinical and subclinical cases is crucial for targeting effective surveillance, hygiene practises, and food safety measures that can mitigate their impact on public health.

背景:Hvittingfoss肠沙门氏菌血清型是非伤寒沙门氏菌群的一员,是在具有主动监测系统的地区(澳大利亚、比利时和美国)最常发现的重要食源性血清型。该血清型与食源性疾病暴发有关。软奶酪、鸡尾酒蟹肉、牛肉和甜瓜通常会引发这些疾病。虽然这种血清型的最终宿主尚未确定,但Hvittingfoss沙门氏菌可以在野生动物(野猪)、鸟类(斑尾金丝雀、羽鸣鸭、白枕鹤和尖尾矶鹬)和家禽(如鸡)中发现。病例介绍:我们报告了首例肠道沙门氏菌血清型Hvittingfoss引起急性胃肠炎的病例,患者为一名来自印度南部迈苏尔农村地区的52岁男性劳工和农学家。这是印度首例记录在案的赫廷福斯沙门氏菌引起急性肠胃炎的病例。结论:虽然非伤寒沙门氏菌感染通常会自行消退,但对于某些人群,如儿童、老年人和免疫系统受损的人群,它们可能特别危险。因此,在临床和亚临床病例中研究这些感染的不同血清型对于制定有效的监测、卫生习惯和食品安全措施以减轻其对公共卫生的影响至关重要。
{"title":"The First-Ever Encounter with <i>Salmonella enterica</i> Serovar Hvittingfoss Causing Acute Gastroenteritis in India: A Case Report.","authors":"Mahadevaiah Neelambike Sumana, Morubagal Raghavendra Rao, Deepashree Rajshekar, Krishna Karthik, Nikita K Shah, Veerabhadra Swamy, Chinchana Shylaja Eshwar, Yogeesh D Maheshwarappa","doi":"10.3390/idr16060094","DOIUrl":"10.3390/idr16060094","url":null,"abstract":"<p><p><b>Background:</b><i>Salmonella enterica</i> serovar Hvittingfoss, a member of the non-typhoidal <i>Salmonella</i> group, is an important foodborne serovar most frequently identified in regions (Australia, Belgium, and the United States) with active surveillance systems. This serovar has been implicated in outbreaks of foodborne illness. Soft cheese, crab cocktail, beef, and rock melon are commonly involved in these outbreaks. Although the definitive host of this serovar is not yet established, <i>Salmonella</i> Hvittingfoss can be found in wild animals (Feral pigs), bird populations (Bar-tailed godwit, Plumed whistling ducks, White-naped crane, and Sharp-tailed sandpiper), and domestic birds like chickens. <b>Case presentation:</b> We report the first case of <i>Salmonella enterica</i> serovar Hvittingfoss causing acute gastroenteritis in a 52-year-old male labourer and agriculturist from a rural area of Mysuru, South India. This is the first documented case of <i>Salmonella</i> Hvittingfoss causing acute gastroenteritis in India. <b>Conclusions:</b> While non-typhoidal <i>Salmonella</i> infections typically resolve on their own, they can be particularly dangerous for certain demographics, such as children, the elderly, and those with compromised immune systems. Therefore, studying the different serotypes of these infections in both clinical and subclinical cases is crucial for targeting effective surveillance, hygiene practises, and food safety measures that can mitigate their impact on public health.</p>","PeriodicalId":13579,"journal":{"name":"Infectious Disease Reports","volume":"16 6","pages":"1191-1196"},"PeriodicalIF":3.4,"publicationDate":"2024-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11675239/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142893516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delayed Diagnosis of Disseminated Invasive Aspergillosis with Purulent Myocarditis in an Immunocompromised Host. 免疫功能低下者弥散性侵袭性曲霉病伴化脓性心肌炎的延迟诊断。
IF 3.4 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-30 DOI: 10.3390/idr16060093
Mark Londema, Maarten W N Nijsten, Joost Bart, Janke S Wiegersma, Bhanu N M Sinha, Douwe F Postma

Introduction: Invasive aspergillosis (IA) is an opportunistic fungal infection that typically occurs in the immunocompromised host and is associated with severe morbidity and mortality. Myocardial abscess formation is seldomly described. Detailed Case Description: We present a case of IA with purulent myocarditis. The patient was on long-term high-dose corticosteroid and mycophenolate mofetil therapy for severe lupus nephritis. After multiple visits to his general practitioner and nephrologist for general malaise, he was admitted to our hospital with visual complaints. Within several days, he developed atrial fibrillation, respiratory insufficiency, and, finally, a decreased level of consciousness. After admission to the intensive care unit, the broncho alveolar lavage (BAL) fluid galactomannan (GM) index was normal, but the serum GM index was severely elevated. Despite initiation of antifungal therapy, the patient passed away shortly thereafter. Autopsy revealed massive intracranial hemorrhage and disseminated IA affecting the lungs, brain, and myocardium, with macroscopic myocardial abscess formation. Discussion: This classic case of diagnostic uncertainty illustrates how invasive fungal infections can progress to disseminated disease while showing nonspecific symptoms only. It emphasizes the importance of vigilance for opportunistic fungal infections in a growing category of immunocompromised patients. Conclusion: Clinicians should have a low threshold of suspicion for fungal infections in patients on combination immunosuppressive medication, such as high-dose corticosteroid therapy in combination with T-cell inhibitors like MMF.

侵袭性曲霉病(IA)是一种机会性真菌感染,通常发生在免疫功能低下的宿主中,并与严重的发病率和死亡率相关。心肌脓肿的形成很少被描述。病例详细描述:我们报告一个合并化脓性心肌炎的IA病例。患者长期接受大剂量皮质类固醇和霉酚酸酯治疗严重狼疮性肾炎。由于全身不适,他多次去看全科医生和肾病科医生后,以视力主诉入院。几天之内,他出现房颤、呼吸功能不全,最后意识水平下降。入住重症监护室后,支气管肺泡灌洗(BAL)液半乳甘露聚糖(GM)指数正常,但血清GM指数严重升高。尽管开始了抗真菌治疗,但患者很快就去世了。尸检发现大量颅内出血和弥散性IA影响肺、脑和心肌,并伴有肉眼可见的心肌脓肿形成。讨论:这个诊断不确定的经典病例说明了侵袭性真菌感染如何在仅表现非特异性症状的情况下发展为播散性疾病。它强调警惕机会性真菌感染在越来越多的免疫功能低下患者的重要性。结论:临床医生对联合使用免疫抑制药物(如大剂量皮质类固醇治疗联合t细胞抑制剂如MMF)的患者的真菌感染应具有低怀疑阈值。
{"title":"Delayed Diagnosis of Disseminated Invasive Aspergillosis with Purulent Myocarditis in an Immunocompromised Host.","authors":"Mark Londema, Maarten W N Nijsten, Joost Bart, Janke S Wiegersma, Bhanu N M Sinha, Douwe F Postma","doi":"10.3390/idr16060093","DOIUrl":"10.3390/idr16060093","url":null,"abstract":"<p><p><b>Introduction:</b> Invasive aspergillosis (IA) is an opportunistic fungal infection that typically occurs in the immunocompromised host and is associated with severe morbidity and mortality. Myocardial abscess formation is seldomly described. <b>Detailed Case Description:</b> We present a case of IA with purulent myocarditis. The patient was on long-term high-dose corticosteroid and mycophenolate mofetil therapy for severe lupus nephritis. After multiple visits to his general practitioner and nephrologist for general malaise, he was admitted to our hospital with visual complaints. Within several days, he developed atrial fibrillation, respiratory insufficiency, and, finally, a decreased level of consciousness. After admission to the intensive care unit, the broncho alveolar lavage (BAL) fluid galactomannan (GM) index was normal, but the serum GM index was severely elevated. Despite initiation of antifungal therapy, the patient passed away shortly thereafter. Autopsy revealed massive intracranial hemorrhage and disseminated IA affecting the lungs, brain, and myocardium, with macroscopic myocardial abscess formation. <b>Discussion:</b> This classic case of diagnostic uncertainty illustrates how invasive fungal infections can progress to disseminated disease while showing nonspecific symptoms only. It emphasizes the importance of vigilance for opportunistic fungal infections in a growing category of immunocompromised patients. <b>Conclusion:</b> Clinicians should have a low threshold of suspicion for fungal infections in patients on combination immunosuppressive medication, such as high-dose corticosteroid therapy in combination with T-cell inhibitors like MMF.</p>","PeriodicalId":13579,"journal":{"name":"Infectious Disease Reports","volume":"16 6","pages":"1182-1190"},"PeriodicalIF":3.4,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11675312/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142894188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing Phage Therapy: A Comprehensive Review of the Safety, Efficacy, and Future Prospects for the Targeted Treatment of Bacterial Infections. 推进噬菌体治疗:对细菌感染靶向治疗的安全性、有效性和未来前景的全面回顾。
IF 3.4 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-28 DOI: 10.3390/idr16060092
Marco Palma, Bowen Qi
<p><strong>Background: </strong>Phage therapy, a treatment utilizing bacteriophages to combat bacterial infections, is gaining attention as a promising alternative to antibiotics, particularly for managing antibiotic-resistant bacteria. This study aims to provide a comprehensive review of phage therapy by examining its safety, efficacy, influencing factors, future prospects, and regulatory considerations. The study also seeks to identify strategies for optimizing its application and to propose a systematic framework for its clinical implementation.</p><p><strong>Methods: </strong>A comprehensive analysis of preclinical studies, clinical trials, and regulatory frameworks was undertaken to evaluate the therapeutic potential of phage therapy. This included an in-depth assessment of key factors influencing clinical outcomes, such as infection site, phage-host specificity, bacterial burden, and immune response. Additionally, innovative strategies-such as combination therapies, bioengineered phages, and phage cocktails-were explored to enhance efficacy. Critical considerations related to dosing, including inoculum size, multiplicity of infection, therapeutic windows, and personalized medicine approaches, were also examined to optimize treatment outcomes.</p><p><strong>Results: </strong>Phage therapy has demonstrated a favorable safety profile in both preclinical and clinical settings, with minimal adverse effects. Its ability to specifically target harmful bacteria while preserving beneficial microbiota underpins its efficacy in treating a range of infections. However, variable outcomes in some studies highlight the importance of addressing critical factors that influence therapeutic success. Innovative approaches, including combination therapies, bioengineered phages, expanded access to diverse phage banks, phage cocktails, and personalized medicine, hold significant promise for improving efficacy. Optimizing dosing strategies remains a key area for enhancement, with critical considerations including inoculum size, multiplicity of infection, phage kinetics, resistance potential, therapeutic windows, dosing frequency, and patient-specific factors. To support the clinical application of phage therapy, a streamlined four-step guideline has been developed, providing a systematic framework for effective treatment planning and implementation.</p><p><strong>Conclusion: </strong>Phage therapy offers a highly adaptable, targeted, and cost-effective approach to addressing antibiotic-resistant infections. While several critical factors must be thoroughly evaluated to optimize treatment efficacy, there remains significant potential for improvement through innovative strategies and refined methodologies. Although phage therapy has yet to achieve widespread approval in the U.S. and Europe, its accessibility through Expanded Access programs and FDA authorizations for food pathogen control underscores its promise. Established practices in countries such as Poland and
背景:噬菌体治疗是一种利用噬菌体对抗细菌感染的治疗方法,作为一种有希望的抗生素替代疗法,特别是在治疗耐药细菌方面,正受到人们的关注。本研究旨在从噬菌体治疗的安全性、有效性、影响因素、未来前景和监管考虑等方面对其进行综述。本研究还旨在确定优化其应用的策略,并为其临床实施提出系统的框架。方法:对临床前研究、临床试验和监管框架进行综合分析,以评估噬菌体疗法的治疗潜力。这包括对影响临床结果的关键因素的深入评估,如感染部位、噬菌体宿主特异性、细菌负担和免疫反应。此外,研究人员还探索了创新策略,如联合疗法、生物工程噬菌体和噬菌体鸡尾酒,以提高疗效。还研究了与剂量相关的关键因素,包括接种量、感染的多样性、治疗窗口和个性化医疗方法,以优化治疗结果。结果:噬菌体疗法在临床前和临床环境中都显示出良好的安全性,副作用最小。它能够特异性地针对有害细菌,同时保留有益微生物群,这巩固了它在治疗一系列感染方面的功效。然而,在一些研究中,不同的结果强调了解决影响治疗成功的关键因素的重要性。包括联合疗法、生物工程噬菌体、扩大获取各种噬菌体库、噬菌体鸡尾酒和个性化药物在内的创新方法,对提高疗效有着重大的希望。优化给药策略仍然是加强的关键领域,关键考虑因素包括接种量、感染的多样性、噬菌体动力学、耐药潜力、治疗窗口、给药频率和患者特异性因素。为了支持噬菌体治疗的临床应用,已经制定了一个简化的四步骤指南,为有效的治疗计划和实施提供了一个系统的框架。结论:噬菌体治疗为解决抗生素耐药感染提供了一种适应性强、针对性强、成本效益高的方法。虽然必须彻底评估几个关键因素以优化治疗效果,但通过创新策略和改进方法仍有很大的改进潜力。尽管噬菌体疗法尚未在美国和欧洲获得广泛批准,但通过扩大准入计划和FDA批准的食品病原体控制的可及性强调了其前景。波兰和格鲁吉亚等国的既定做法进一步证明了其临床可行性。为了实现更广泛的采用,生产、交付和质量控制方面的监管协调和进步将是必不可少的。值得注意的是,噬菌体治疗的可负担性和可扩展性使其成为发展中地区应对抗生素耐药性上升的特别有价值的解决方案。
{"title":"Advancing Phage Therapy: A Comprehensive Review of the Safety, Efficacy, and Future Prospects for the Targeted Treatment of Bacterial Infections.","authors":"Marco Palma, Bowen Qi","doi":"10.3390/idr16060092","DOIUrl":"10.3390/idr16060092","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Phage therapy, a treatment utilizing bacteriophages to combat bacterial infections, is gaining attention as a promising alternative to antibiotics, particularly for managing antibiotic-resistant bacteria. This study aims to provide a comprehensive review of phage therapy by examining its safety, efficacy, influencing factors, future prospects, and regulatory considerations. The study also seeks to identify strategies for optimizing its application and to propose a systematic framework for its clinical implementation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A comprehensive analysis of preclinical studies, clinical trials, and regulatory frameworks was undertaken to evaluate the therapeutic potential of phage therapy. This included an in-depth assessment of key factors influencing clinical outcomes, such as infection site, phage-host specificity, bacterial burden, and immune response. Additionally, innovative strategies-such as combination therapies, bioengineered phages, and phage cocktails-were explored to enhance efficacy. Critical considerations related to dosing, including inoculum size, multiplicity of infection, therapeutic windows, and personalized medicine approaches, were also examined to optimize treatment outcomes.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Phage therapy has demonstrated a favorable safety profile in both preclinical and clinical settings, with minimal adverse effects. Its ability to specifically target harmful bacteria while preserving beneficial microbiota underpins its efficacy in treating a range of infections. However, variable outcomes in some studies highlight the importance of addressing critical factors that influence therapeutic success. Innovative approaches, including combination therapies, bioengineered phages, expanded access to diverse phage banks, phage cocktails, and personalized medicine, hold significant promise for improving efficacy. Optimizing dosing strategies remains a key area for enhancement, with critical considerations including inoculum size, multiplicity of infection, phage kinetics, resistance potential, therapeutic windows, dosing frequency, and patient-specific factors. To support the clinical application of phage therapy, a streamlined four-step guideline has been developed, providing a systematic framework for effective treatment planning and implementation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Phage therapy offers a highly adaptable, targeted, and cost-effective approach to addressing antibiotic-resistant infections. While several critical factors must be thoroughly evaluated to optimize treatment efficacy, there remains significant potential for improvement through innovative strategies and refined methodologies. Although phage therapy has yet to achieve widespread approval in the U.S. and Europe, its accessibility through Expanded Access programs and FDA authorizations for food pathogen control underscores its promise. Established practices in countries such as Poland and","PeriodicalId":13579,"journal":{"name":"Infectious Disease Reports","volume":"16 6","pages":"1127-1181"},"PeriodicalIF":3.4,"publicationDate":"2024-11-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11675988/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142894174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multidisciplinary Approach of a Male Case of Imported Malaria, HIV Chronic Infection, and Latent Syphilis. 输入性疟疾、HIV慢性感染和潜伏性梅毒男性病例的多学科分析。
IF 3.4 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-27 DOI: 10.3390/idr16060091
Rebeca Eunice García-Mendiola, Maritza Micheli García-Lucas, Jennifer Morales-Vázquez, Raúl Adrián Cruz-Flores, Miguel Ángel Loyola-Cruz, Clemente Cruz-Cruz, Emilio Mariano Durán-Manuel, Enzo Vásquez-Jiménez, Graciela Castro-Escarpulli, María de Jesús Sánchez-Guzmán, Victor Hugo Gutiérrez-Muñoz, Iliana Alejandra Cortés-Ortíz, Misael González-Ibarra, Juan Carlos Bravata-Alcántara, Jesús Alejandro Pineda-Migranas, Estibeyesbo Said Plascencia-Nieto, Carlos Alberto Jiménez-Zamarripa, Erika Gómez-Zamora, Claudia Camelia Calzada-Mendoza, Juan Manuel Bello-López

Background: The current economic and social crisis in Latin America has caused migration to the USA, bringing with it Public Health challenges due to the importation of various infectious diseases. Migrants, particularly those with chronic conditions, such as HIV infection and other sexually transmitted infections (STI), are at greater risk due to pharmacological interruption and access to medical care, so the timely detection of diseases acquired during their migration, such as malaria, is crucial to avoid health complications.

Objective: To outline by a multidisciplinary approach (Infectology, Parasitology, Epidemiology, molecular Biology, Venereology, and Public Health) the diagnosis and management of a male case with malaria imported to Mexican territory, HIV chronic infection, and latent syphilis.

Methods: A male migrant of Venezuelan nationality attended the Clínica Especializada Condesa Iztapalapa in Mexico City for health complications. A comprehensive analysis of laboratory and molecular tests was performed to confirm HIV infection. During the STI diagnostic algorithm, latent syphilis was detected and microscopic observation of blood smears revealed parasitic forms compatible with malaria. Standard and molecular tests were applied under the operational definition for malaria cases for identification, diagnosis, and treatment. Finally, study of clinical history and migration route by questioning for the investigation of the imported case was performed.

Results: The immigrant was diagnosed with HIV chronic-stage infection with interrupted antiretroviral therapy (ART), latent syphilis, and malaria by Plasmodium vivax. The ART administered was chosen based on the possible drug interaction with antimalarials and genetic barrier to the HLA-B* allele. Finally, antimicrobial therapy against syphilis was penicillin. From the analysis of the migratory route, incubation time of imported malaria, and questioning, we speculated that the migrant acquired the P. vivax infection in Panama.

Conclusions: This case highlights the complex health problems faced by migrants with HIV infection, particularly when they contract additional infections such as malaria during migration and highlights the need for comprehensive access to healthcare and ART, antimalarial and antimicrobial treatments to mitigate the health risks of this vulnerable population.

背景:当前拉丁美洲的经济和社会危机导致移民到美国,由于各种传染病的输入,带来了公共卫生挑战。移徙者,特别是那些患有慢性疾病,如感染艾滋病毒和其他性传播感染的移徙者,由于药物中断和无法获得医疗服务,面临更大的风险,因此及时发现移徙期间感染的疾病,如疟疾,对于避免健康并发症至关重要。目的:通过多学科方法(感染学、寄生虫学、流行病学、分子生物学、性病学和公共卫生)概述一例输入性疟疾、HIV慢性感染和潜伏性梅毒男性病例的诊断和处理。方法:1例委内瑞拉籍男性移民因健康并发症到墨西哥市Clínica特别医院就诊。对实验室和分子检测进行了全面分析,以确认艾滋病毒感染。在STI诊断算法中,检测到潜伏梅毒,血液涂片显微镜观察发现与疟疾相容的寄生虫形式。根据业务定义,对疟疾病例采用标准和分子检测,以进行识别、诊断和治疗。最后,通过询问的方式对输入病例的临床病史和迁移途径进行调查。结果:该移民被诊断为HIV慢性感染,经中断抗逆转录病毒治疗(ART),潜伏梅毒,间日疟原虫感染疟疾。根据药物与抗疟药可能的相互作用和HLA-B*等位基因的遗传屏障来选择抗逆转录病毒疗法。最后,治疗梅毒的抗菌药物是青霉素。从迁徙路线、输入性疟疾潜伏期及询问等方面分析,推测该迁徙者在巴拿马获得间日疟原虫感染。结论:这一案例突出了感染艾滋病毒的移徙者面临的复杂健康问题,特别是当他们在移徙期间感染疟疾等其他感染时,并突出了需要全面获得医疗保健和抗逆转录病毒治疗、抗疟疾和抗微生物治疗,以减轻这一弱势群体的健康风险。
{"title":"Multidisciplinary Approach of a Male Case of Imported Malaria, HIV Chronic Infection, and Latent Syphilis.","authors":"Rebeca Eunice García-Mendiola, Maritza Micheli García-Lucas, Jennifer Morales-Vázquez, Raúl Adrián Cruz-Flores, Miguel Ángel Loyola-Cruz, Clemente Cruz-Cruz, Emilio Mariano Durán-Manuel, Enzo Vásquez-Jiménez, Graciela Castro-Escarpulli, María de Jesús Sánchez-Guzmán, Victor Hugo Gutiérrez-Muñoz, Iliana Alejandra Cortés-Ortíz, Misael González-Ibarra, Juan Carlos Bravata-Alcántara, Jesús Alejandro Pineda-Migranas, Estibeyesbo Said Plascencia-Nieto, Carlos Alberto Jiménez-Zamarripa, Erika Gómez-Zamora, Claudia Camelia Calzada-Mendoza, Juan Manuel Bello-López","doi":"10.3390/idr16060091","DOIUrl":"10.3390/idr16060091","url":null,"abstract":"<p><strong>Background: </strong>The current economic and social crisis in Latin America has caused migration to the USA, bringing with it Public Health challenges due to the importation of various infectious diseases. Migrants, particularly those with chronic conditions, such as HIV infection and other sexually transmitted infections (STI), are at greater risk due to pharmacological interruption and access to medical care, so the timely detection of diseases acquired during their migration, such as malaria, is crucial to avoid health complications.</p><p><strong>Objective: </strong>To outline by a multidisciplinary approach (Infectology, Parasitology, Epidemiology, molecular Biology, Venereology, and Public Health) the diagnosis and management of a male case with malaria imported to Mexican territory, HIV chronic infection, and latent syphilis.</p><p><strong>Methods: </strong>A male migrant of Venezuelan nationality attended the Clínica Especializada Condesa Iztapalapa in Mexico City for health complications. A comprehensive analysis of laboratory and molecular tests was performed to confirm HIV infection. During the STI diagnostic algorithm, latent syphilis was detected and microscopic observation of blood smears revealed parasitic forms compatible with malaria. Standard and molecular tests were applied under the operational definition for malaria cases for identification, diagnosis, and treatment. Finally, study of clinical history and migration route by questioning for the investigation of the imported case was performed.</p><p><strong>Results: </strong>The immigrant was diagnosed with HIV chronic-stage infection with interrupted antiretroviral therapy (ART), latent syphilis, and malaria by <i>Plasmodium vivax</i>. The ART administered was chosen based on the possible drug interaction with antimalarials and genetic barrier to the HLA-B* allele. Finally, antimicrobial therapy against syphilis was penicillin. From the analysis of the migratory route, incubation time of imported malaria, and questioning, we speculated that the migrant acquired the <i>P. vivax</i> infection in Panama.</p><p><strong>Conclusions: </strong>This case highlights the complex health problems faced by migrants with HIV infection, particularly when they contract additional infections such as malaria during migration and highlights the need for comprehensive access to healthcare and ART, antimalarial and antimicrobial treatments to mitigate the health risks of this vulnerable population.</p>","PeriodicalId":13579,"journal":{"name":"Infectious Disease Reports","volume":"16 6","pages":"1118-1126"},"PeriodicalIF":3.4,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11675952/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142894241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effectiveness of Topical Treatment for Plantar Warts: A Retrospective Cohort Study. 局部治疗足底疣的有效性:回顾性队列研究。
IF 3.4 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-26 DOI: 10.3390/idr16060090
Ana Mª Rayo Pérez, José María Juárez Jiménez, Rafael Rayo Rosado, Raquel García de la Peña

Background: Plantar warts, caused by human papillomavirus (HPV), are a common condition that can be painful and resistant to treatment. There are various therapeutic options for managing them, but it is not always clear which are the most effective and tolerated by patients. Among the most commonly used treatments are a zinc and nitric complex (nitrizinc complex), cantharidin, and bleomycin, each with different mechanisms of action and profiles in terms of pain and patient satisfaction. Objectives: We aimed to evaluate and compare the clinical efficacy, post-treatment pain, and patient satisfaction among three common treatments (zinc and nitric complex, cantharidin, and bleomycin) in subjects with plantar warts, as well as identify the most effective and best-tolerated treatment. Materials and Methods: This is a retrospective case series study analyzing 60 records of subjects aged 18 to 40 years diagnosed with plantar warts without systemic diseases or allergies and without any prior treatment. Complete records from 2020 to 2023 were selected. Subjects were divided into three groups according to the treatment received (zinc and nitric complex, cantharidin, bleomycin), and demographic variables, post-treatment pain (measured using the visual analog scale), the number of sessions required, and satisfaction after discharge (evaluated with the Likert scale) were analyzed. Results: Of the 60 subjects included, the group treated with bleomycin experienced higher levels of pain after the first session (mean of 7.1 points on the VAS) compared to the cantharidin group (2.7 points) and the zinc and nitric complex group (1.1 points). However, the bleomycin group required fewer sessions for complete healing (an average of 1.8 sessions), while the nitric acid group needed more (3.4 sessions), with cantharidin falling in between (2.5 sessions). Regarding post-discharge satisfaction, all groups showed comparable scores (between 7.9 and 8.5 points), although cantharidin demonstrated slightly higher satisfaction. A statistical analysis showed significant differences in the number of sessions and post-treatment pain between treatments (p < 0.05) but not in final satisfaction. Conclusions: Although bleomycin treatment is more painful, it is the most effective in terms of reducing the number of sessions required for complete healing. Cantharidin offers a good balance between efficacy and patient satisfaction, while a zinc and nitric complex, although less painful, requires more sessions for complete treatment. Each treatment has specific advantages, suggesting that therapeutic choices should be personalized according to the patient's needs and preferences.

背景:由人乳头瘤病毒(HPV)引起的足底疣是一种常见的疾病,可能会引起疼痛并对治疗产生抗药性。有多种治疗方法来控制它们,但并不总是清楚哪一种是最有效和最能被患者耐受的。最常用的治疗方法是锌和硝酸复合物(氮锌复合物),斑蝥素和博来霉素,每一种都有不同的作用机制和在疼痛和患者满意度方面的特点。目的:我们旨在评估和比较三种常见治疗方法(锌和硝酸复合物、斑蝥素和博来霉素)对足底疣患者的临床疗效、治疗后疼痛和患者满意度,并确定最有效和最耐受的治疗方法。材料和方法:这是一项回顾性病例系列研究,分析了60例年龄在18至40岁之间诊断为足底疣,无全身性疾病或过敏且未接受任何治疗的受试者。选取2020 - 2023年的完整记录。根据所接受的治疗(锌和一氧化氮复合物、cantharidin、博来霉素)和人口学变量将受试者分为三组,分析治疗后疼痛(使用视觉模拟量表测量)、所需疗程数和出院后满意度(使用Likert量表评估)。结果:在纳入的60名受试者中,与斑蝥素组(2.7分)和锌和硝酸复合物组(1.1分)相比,博来霉素组在第一次治疗后经历了更高水平的疼痛(VAS平均7.1分)。然而,博莱霉素组需要更少的疗程才能完全愈合(平均1.8次),而硝酸组需要更多(3.4次),斑蝥素介于两者之间(2.5次)。关于出院后满意度,虽然斑蝥素表现出稍高的满意度,但所有组的得分相当(在7.9到8.5分之间)。经统计学分析,两组患者治疗次数和治疗后疼痛差异有统计学意义(p < 0.05),但最终满意度差异无统计学意义。结论:虽然博来霉素治疗更痛苦,但在减少完全愈合所需的疗程数量方面,它是最有效的。斑蝥素在疗效和患者满意度之间提供了很好的平衡,而锌和一氧化氮复合物虽然疼痛较少,但需要更多的疗程才能完成治疗。每一种治疗方法都有其独特的优势,这表明治疗选择应根据患者的需要和偏好进行个性化。
{"title":"The Effectiveness of Topical Treatment for Plantar Warts: A Retrospective Cohort Study.","authors":"Ana Mª Rayo Pérez, José María Juárez Jiménez, Rafael Rayo Rosado, Raquel García de la Peña","doi":"10.3390/idr16060090","DOIUrl":"10.3390/idr16060090","url":null,"abstract":"<p><p><b>Background</b>: Plantar warts, caused by human papillomavirus (HPV), are a common condition that can be painful and resistant to treatment. There are various therapeutic options for managing them, but it is not always clear which are the most effective and tolerated by patients. Among the most commonly used treatments are a zinc and nitric complex (nitrizinc complex), cantharidin, and bleomycin, each with different mechanisms of action and profiles in terms of pain and patient satisfaction. <b>Objectives</b>: We aimed to evaluate and compare the clinical efficacy, post-treatment pain, and patient satisfaction among three common treatments (zinc and nitric complex, cantharidin, and bleomycin) in subjects with plantar warts, as well as identify the most effective and best-tolerated treatment. <b>Materials and Methods</b>: This is a retrospective case series study analyzing 60 records of subjects aged 18 to 40 years diagnosed with plantar warts without systemic diseases or allergies and without any prior treatment. Complete records from 2020 to 2023 were selected. Subjects were divided into three groups according to the treatment received (zinc and nitric complex, cantharidin, bleomycin), and demographic variables, post-treatment pain (measured using the visual analog scale), the number of sessions required, and satisfaction after discharge (evaluated with the Likert scale) were analyzed. <b>Results</b>: Of the 60 subjects included, the group treated with bleomycin experienced higher levels of pain after the first session (mean of 7.1 points on the VAS) compared to the cantharidin group (2.7 points) and the zinc and nitric complex group (1.1 points). However, the bleomycin group required fewer sessions for complete healing (an average of 1.8 sessions), while the nitric acid group needed more (3.4 sessions), with cantharidin falling in between (2.5 sessions). Regarding post-discharge satisfaction, all groups showed comparable scores (between 7.9 and 8.5 points), although cantharidin demonstrated slightly higher satisfaction. A statistical analysis showed significant differences in the number of sessions and post-treatment pain between treatments (<i>p</i> < 0.05) but not in final satisfaction. <b>Conclusions</b>: Although bleomycin treatment is more painful, it is the most effective in terms of reducing the number of sessions required for complete healing. Cantharidin offers a good balance between efficacy and patient satisfaction, while a zinc and nitric complex, although less painful, requires more sessions for complete treatment. Each treatment has specific advantages, suggesting that therapeutic choices should be personalized according to the patient's needs and preferences.</p>","PeriodicalId":13579,"journal":{"name":"Infectious Disease Reports","volume":"16 6","pages":"1108-1117"},"PeriodicalIF":3.4,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11675367/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142894244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of the COVID-19 Pandemic on the Detection of Leprosy in Micro-Regions with a High Risk of Illness in Minas Gerais, Brazil. 2019冠状病毒病大流行对巴西米纳斯吉拉斯州疾病高风险微地区麻风病检出率的影响
IF 3.4 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-26 DOI: 10.3390/idr16060089
Sarah Lamas Vidal, Daniele Dos Santos Lages, Isabela Cristina Lana Maciel, Isabel Cristina Gonçalves Leite, Angélica da Conceição Oliveira Coelho, Francisco Carlos Félix Lana

Background: Leprosy control remains challenging in Brazil and has been aggravated by the COVID-19 pandemic.

Objective: To analyze the impact of the COVID-19 pandemic on the epidemiological scenario of leprosy through the detection rate of new cases, the risk of illness, and the hidden prevalence of leprosy according to high-risk micro-region in Minas Gerais, Brazil.

Methods: An ecological study conducted in the health micro-regions of Minas Gerais, using data on new leprosy cases diagnosed between 2015 and 2023. The annual detection rate of new cases, the risk of illness index and the hidden prevalence of leprosy were evaluated. The time trend was evaluated by calculating the annual percentage change (APC) of the detection rate, based on segmented linear regression, considered significant when it showed p < 0.05.

Results: The state of Minas Gerais showed a significant negative annual increase between 2015 and 2020 (APC = -7.91; 95%CI -21.76--1.72), and in 2020 it showed an inflection point, with an annual increase of 9.91 in the period from 2020 to 2023. When evaluating the hidden prevalence of leprosy in Minas Gerais, we observed a reduction in the estimates' average from 2015-2019 (2.78) to 2020-2023 (2.00). The state as a whole showed an upward trend in the risk of illness, with the average index varying from 0.28 (medium risk) to 0.55 (high risk).

Conclusions: The pandemic has had a considerable and heterogeneous impact on the detection of new cases, as well as on the risk of becoming ill and the hidden prevalence of leprosy, with repercussions for the control of the endemic in populations. There is a need to implement public health policies that prioritize the early identification of cases and ensure that vulnerable populations are monitored.

背景:在巴西,控制麻风病仍然具有挑战性,并因COVID-19大流行而恶化。目的:通过对巴西米纳斯吉拉斯州高危微区麻风病新发病例检出率、发病风险及隐性流行情况的分析,分析2019冠状病毒病疫情对当地麻风病流行情景的影响。方法:利用2015年至2023年期间新诊断的麻风病例数据,在米纳斯吉拉斯州的卫生微区进行了一项生态研究。评估年新发病例检出率、疾病风险指数和麻风隐性患病率。通过计算检出率的年百分比变化(APC)来评估时间趋势,基于分段线性回归,当p < 0.05时认为显著。结果:2015 - 2020年,米纳斯吉拉斯州呈显著的负增长(APC = -7.91;95%CI -21.76—1.72),2020年出现拐点,2020 - 2023年年均增长9.91。在评估米纳斯吉拉斯州麻风病隐藏流行率时,我们观察到2015-2019年平均值(2.78)降至2020-2023年平均值(2.00)。从整体上看,患病风险呈上升趋势,平均指数从0.28(中等风险)到0.55(高风险)不等。结论:这次大流行对发现新病例、患病风险和麻风病的隐性流行产生了相当大的不同程度的影响,并对控制人群中的麻风病产生了影响。有必要实施公共卫生政策,优先及早发现病例,并确保对弱势群体进行监测。
{"title":"Impact of the COVID-19 Pandemic on the Detection of Leprosy in Micro-Regions with a High Risk of Illness in Minas Gerais, Brazil.","authors":"Sarah Lamas Vidal, Daniele Dos Santos Lages, Isabela Cristina Lana Maciel, Isabel Cristina Gonçalves Leite, Angélica da Conceição Oliveira Coelho, Francisco Carlos Félix Lana","doi":"10.3390/idr16060089","DOIUrl":"10.3390/idr16060089","url":null,"abstract":"<p><strong>Background: </strong>Leprosy control remains challenging in Brazil and has been aggravated by the COVID-19 pandemic.</p><p><strong>Objective: </strong>To analyze the impact of the COVID-19 pandemic on the epidemiological scenario of leprosy through the detection rate of new cases, the risk of illness, and the hidden prevalence of leprosy according to high-risk micro-region in Minas Gerais, Brazil.</p><p><strong>Methods: </strong>An ecological study conducted in the health micro-regions of Minas Gerais, using data on new leprosy cases diagnosed between 2015 and 2023. The annual detection rate of new cases, the risk of illness index and the hidden prevalence of leprosy were evaluated. The time trend was evaluated by calculating the annual percentage change (APC) of the detection rate, based on segmented linear regression, considered significant when it showed <i>p</i> < 0.05.</p><p><strong>Results: </strong>The state of Minas Gerais showed a significant negative annual increase between 2015 and 2020 (APC = -7.91; 95%CI -21.76--1.72), and in 2020 it showed an inflection point, with an annual increase of 9.91 in the period from 2020 to 2023. When evaluating the hidden prevalence of leprosy in Minas Gerais, we observed a reduction in the estimates' average from 2015-2019 (2.78) to 2020-2023 (2.00). The state as a whole showed an upward trend in the risk of illness, with the average index varying from 0.28 (medium risk) to 0.55 (high risk).</p><p><strong>Conclusions: </strong>The pandemic has had a considerable and heterogeneous impact on the detection of new cases, as well as on the risk of becoming ill and the hidden prevalence of leprosy, with repercussions for the control of the endemic in populations. There is a need to implement public health policies that prioritize the early identification of cases and ensure that vulnerable populations are monitored.</p>","PeriodicalId":13579,"journal":{"name":"Infectious Disease Reports","volume":"16 6","pages":"1098-1107"},"PeriodicalIF":3.4,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11675893/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142894239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SARS-CoV-2 Immunization Index in the Academic Community: A Retrospective Post-Vaccination Study. 学术界SARS-CoV-2免疫指数:疫苗接种后的回顾性研究
IF 3.4 Q2 INFECTIOUS DISEASES Pub Date : 2024-11-25 DOI: 10.3390/idr16060088
Keltyn Oliveira, Ana Almeida, Carina Silva, Miguel Brito, Edna Ribeiro

Background/objectives: The COVID-19 pandemic has revolutionized vaccine production and compelled a massive global vaccination campaign. This study aimed to estimate the positivity and levels of SARS-CoV-2 IgG antibodies acquired due to vaccination and infection in the academic population of a Portuguese university.

Methods: Blood samples were collected and analyzed through the ELISA methodology, and statistical analysis was performed.

Results: A total of 529 volunteers with at least one dose of the vaccine were enrolled in this study. Individuals without a prior COVID-19 diagnosis were divided into two groups: 350, who received a full vaccination, and 114, who received a full vaccination and a booster dose of the same vaccine (81) and mixed vaccines (33). Regarding the individuals who reported a prior SARS-CoV-2 infection, 31 received a full vaccination, and 34 received only one vaccination dose. Data analysis showed a higher level of IgG against SARS-CoV-2 in individuals who were younger, female, who received the Moderna vaccine, with recent post-vaccine administration, a mixed booster dose, and prior SARS-CoV-2 infection.

Conclusions: Assessing vaccination's effectiveness and group immunity is crucial for pandemic management, particularly in academic environments with high individual mobility, in order to define groups at risk and redirect infection control strategies.

背景/目标:2019冠状病毒病大流行彻底改变了疫苗生产,迫使全球开展大规模疫苗接种运动。本研究旨在估计葡萄牙一所大学学术人群因接种疫苗和感染而获得的SARS-CoV-2 IgG抗体的阳性和水平。方法:采用ELISA法采集血样进行分析,并进行统计学分析。结果:共有529名至少接种了一剂疫苗的志愿者参加了这项研究。之前没有COVID-19诊断的个体被分为两组:350人接受了全面疫苗接种,114人接受了全面疫苗接种和同一疫苗的加强剂(81人)和混合疫苗(33人)。在报告先前感染过SARS-CoV-2的个体中,31人接受了完整的疫苗接种,34人只接受了一剂疫苗接种。数据分析显示,年轻、女性、接种现代疫苗、近期接种疫苗后、混合加强剂量和既往感染过SARS-CoV-2的个体中,针对SARS-CoV-2的IgG水平较高。结论:评估疫苗接种的有效性和群体免疫对于大流行管理至关重要,特别是在个人流动性高的学术环境中,以便确定有风险的群体并重新制定感染控制策略。
{"title":"SARS-CoV-2 Immunization Index in the Academic Community: A Retrospective Post-Vaccination Study.","authors":"Keltyn Oliveira, Ana Almeida, Carina Silva, Miguel Brito, Edna Ribeiro","doi":"10.3390/idr16060088","DOIUrl":"10.3390/idr16060088","url":null,"abstract":"<p><strong>Background/objectives: </strong>The COVID-19 pandemic has revolutionized vaccine production and compelled a massive global vaccination campaign. This study aimed to estimate the positivity and levels of SARS-CoV-2 IgG antibodies acquired due to vaccination and infection in the academic population of a Portuguese university.</p><p><strong>Methods: </strong>Blood samples were collected and analyzed through the ELISA methodology, and statistical analysis was performed.</p><p><strong>Results: </strong>A total of 529 volunteers with at least one dose of the vaccine were enrolled in this study. Individuals without a prior COVID-19 diagnosis were divided into two groups: 350, who received a full vaccination, and 114, who received a full vaccination and a booster dose of the same vaccine (81) and mixed vaccines (33). Regarding the individuals who reported a prior SARS-CoV-2 infection, 31 received a full vaccination, and 34 received only one vaccination dose. Data analysis showed a higher level of IgG against SARS-CoV-2 in individuals who were younger, female, who received the Moderna vaccine, with recent post-vaccine administration, a mixed booster dose, and prior SARS-CoV-2 infection.</p><p><strong>Conclusions: </strong>Assessing vaccination's effectiveness and group immunity is crucial for pandemic management, particularly in academic environments with high individual mobility, in order to define groups at risk and redirect infection control strategies.</p>","PeriodicalId":13579,"journal":{"name":"Infectious Disease Reports","volume":"16 6","pages":"1084-1097"},"PeriodicalIF":3.4,"publicationDate":"2024-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11675320/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142894243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Infectious Disease Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1